Sleep Apnea Devices Market Set for Consistent Expansion Driven by Technological Advancements and Rising Surgical Procedures | DelveInsight

The global sleep apnea devices market is growing at a CAGR of 6.58% during the forecast period from 2025 to 2032.
The global sleep apnea devices market, estimated at USD 7.53 billion in 2023, is anticipated to expand at a CAGR of 6.26% between 2024 and 2030, reaching approximately USD 10.82 billion by 2030. This growth is primarily attributed to the increasing prevalence of sleep apnea, rising obesity levels, and accelerating adoption of advanced medical technologies. Moreover, growing disease awareness, an aging population, and a steady rise in product launches and regulatory approvals are expected to further propel market growth through 2030.

DelveInsight's Sleep Apnea Devices Market Insights report delivers comprehensive market intelligence, covering current and forecast trends, market share of key players, growth drivers and barriers, and emerging opportunities shaping the competitive landscape of the global sleep apnea devices market.

Request for a sample page report @ https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr

Key Takeaways from the Sleep Apnea Devices Market Report

The Sleep Apnea Devices market is expected to register moderate growth at a steady CAGR between 2025 and 2032. According to DelveInsight estimates, North America is projected to remain the leading region in the global Sleep Apnea Devices market throughout the forecast period.

Several prominent players are actively contributing to market development, including Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd., Vivos Therapeutics, Inc., Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics GmbH, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Key recent developments include:

*
September 2024: Vivos Therapeutics, Inc. received FDA 510(k) clearance for its oral medical device aimed at treating moderate to severe obstructive sleep apnea (OSA) and snoring in children, reinforcing its commitment to improving pediatric sleep health.

*
October 2022: Airway Management launched flexTAP, a premium, custom-made oral appliance designed to manage snoring and mild to moderate OSA.

*
August 2021: Vivos Therapeutics, Inc. secured FDA approval for its intraoral devices targeting snoring and OSA.

*
March 2020: Signifier Medical Technologies obtained FDA clearance for eXciteOSA, a neuromuscular tongue stimulator developed to reduce snoring and obstructive sleep apnea symptoms.

To read more about the latest highlights related to the Sleep Apnea Devices market, get a snapshot of the key highlights entailed in the Global Sleep Apnea Devices Market Report [https://www.delveinsight.com/sample-request/sleep-apnea-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Sleep Apnea Devices Overview

Sleep apnea devices are developed to detect and treat sleep apnea, a condition marked by recurrent pauses in breathing during sleep. This disorder often results in disrupted sleep patterns, daytime tiredness, and can contribute to serious long-term health complications, including cardiovascular diseases.

Sleep Apnea Devices Market Insights

North America is anticipated to dominate the sleep apnea devices market in 2023, primarily due to the growing prevalence of sleep apnea and insomnia, an aging population, and an increase in chronic nasal congestion cases. Other key factors supporting this growth include high disposable income levels, a well-established healthcare infrastructure, favorable regulatory frameworks, and greater awareness of sleep apnea diagnosis and treatment options.

As per the CDC (2022), about 14.5% of U.S. adults in 2020 reported difficulty falling asleep on most days, with the issue being more common among older individuals and certain demographic groups. Such sleep disturbances can contribute to insomnia, anxiety, depression, daytime fatigue, and breathing disorders like obstructive sleep apnea (OSA)-often associated with snoring due to weakened pharyngeal muscles during sleep. The increasing focus on addressing these conditions is projected to further drive the regional demand for sleep apnea devices.

To know more about why North America is leading the market growth in the Sleep Apnea Devices market, get a snapshot of the Sleep Apnea Devices Market Outlook [https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Sleep Apnea Devices Market Dynamics

The sleep apnea devices market is witnessing steady growth, largely driven by the increasing incidence of comorbid conditions such as diabetes, asthma, and sinusitis. Among these, diabetes plays a particularly significant role, as it can impair respiratory control and airway reflexes, heightening the risk of sleep-related breathing disorders and the need for therapeutic support devices. According to the IDF Diabetes Atlas 2021, more than 537 million adults worldwide are affected by diabetes, a number expected to rise to 643 million by 2030, thereby contributing to the growing demand for sleep apnea management solutions.

In the United States, market expansion is further supported by a high prevalence of sleep disorders, advanced diagnostic capabilities, rising awareness levels, and the strong presence of both global and local manufacturers offering a range of CPAP machines, oral appliances, and wearable devices. Additionally, increasing investments in telehealth, homecare services, and research and development aimed at improving patient comfort, convenience, and adherence are expected to further propel market growth in the coming years.

Sleep Apnea Devices Market Drivers:

*
Increasing prevalence of sleep apnea

*
Rising geriatric population base across the globe

Get a sneak peek at the Sleep Apnea Devices market dynamics [https://www.delveinsight.com/sample-request/sleep-apnea-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Scope of the Sleep Apnea Devices Market Report:

*
Coverage: Global

*
Study Period: 2022 to 2032

*
Key Sleep Apnea Devices Companies: Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Which MedTech key players in the Sleep Apnea Devices market are set to emerge as the trendsetter, explore @ Sleep Apnea Devices Companies [https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sleep-apnea-devices-market-set-for-consistent-expansion-driven-by-technological-advancements-and-rising-surgical-procedures-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.